Evidence map›Paper›PMID 27264182›Full record

ArticleCell reports2016

Defining the Minimal Factors Required for Erythropoiesis through Direct Lineage Conversion.

Sandra Capellera-Garcia, Julian Pulecio, Kishori Dhulipala, Kavitha Siva, Violeta Rayon-Estrada, Sofie Singbrant, Mikael N E Sommarin, Carl R Walkley, Shamit Soneji, Göran Karlsson and 3 more

Abstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Transcription Factor TAL1 in Erythropoiesis.Advances in experimental medicine and biology · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sandra Capellera-GarciaDepartment of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Julian PulecioCenter of Regenerative Medicine in Barcelona, Barcelona Biomedical Research Park, Doctor Aiguader 88, 08003 Barcelona, Spain.
Kishori DhulipalaDepartment of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Kavitha SivaDepartment of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Violeta Rayon-EstradaThe Rockefeller University, New York, NY 10065, USA.
Sofie SingbrantDepartment of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Mikael N E SommarinDivision of Molecular Hematology, BMC B12, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Carl R WalkleySt. Vincent's Institute of Medical Research and Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
Shamit SonejiDivision of Molecular Hematology, BMC B12, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Göran KarlssonDivision of Molecular Hematology, BMC B12, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden.
Ángel RayaCenter of Regenerative Medicine in Barcelona, Barcelona Biomedical Research Park, Doctor Aiguader 88, 08003 Barcelona, Spain; Catalan Institution for Research and Advanced Studies, 08010 Barcelona, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain.
Vijay G SankaranDivision of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.
Johan FlygareDepartment of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, 22184 Lund, Sweden. Electronic address: johan.flygare@med.lu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythroid cell commitment and differentiation proceed through activation of a lineage-restricted transcriptional network orchestrated by a group of well characterized genes. However, the minimal set of factors necessary for instructing red blood cell (RBC) development remains undefined. We employed a screen for transcription factors allowing direct lineage reprograming from fibroblasts to induced erythroid progenitors/precursors (iEPs). We show that Gata1, Tal1, Lmo2, and c-Myc (GTLM) can rapidly convert murine and human fibroblasts directly to iEPs. The transcriptional signature of murine iEPs resembled mainly that of primitive erythroid progenitors in the yolk sac, whereas addition of Klf1 or Myb to the GTLM cocktail resulted in iEPs with a more adult-type globin expression pattern. Our results demonstrate that direct lineage conversion is a suitable platform for defining and studying the core factors inducing the different waves of erythroid development.

Indexed as

Cell LineageErythropoiesisAgingAnimalsCell DifferentiationCellular ReprogrammingColony-Forming Units AssayErythroblastsFibroblastsGene Expression ProfilingGene Expression RegulationGlobinsHumansMice, Inbred C57BLTranscription FactorsGlobinsTranscription Factors

Identifiers

PMID27264182
PMCPMC4914771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.